Experience with the Crescent® cannula for adult respiratory VV ECMO : a case series
INTRODUCTION: The Crescent® is a recently introduced dual lumen cannula by which veno-venous extracorporeal membrane oxygenation (VV ECMO) is delivered. It has a number of features that enhance its ease of placement, pressure-flow dynamics and may reduce catheter-related complication rates.
METHODS: We present the first case series of its kind analysing this device by means of a retrospective observational study of prospectively collected data from the first year of its use in a high volume severe acute respiratory failure centre (Glenfield, UK). We compare complication rates of the Crescent®, with data from the international ELSO database and our own historic centre data and discuss subjective clinician experience of introducing this device.
RESULTS: Over the first 12 months of its use (23/09/2019-23/09/2020), 54 patients were cannulated using a Crescent® catheter. There were no serious/life-threatening adverse events and a low number of minor cannula-related complications. Subjectively users found it has a number of advantages over other devices and configurations, not captured within current data collection frameworks.
CONCLUSION: The Crescent® is a safe and effective device by which to deliver VV ECMO support to patients with severe acute respiratory failure.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Perfusion - 37(2022), 8 vom: 17. Nov., Seite 819-824 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fleet, Daniel [VerfasserIn] |
---|
Links: |
---|
Themen: |
Crescent |
---|
Anmerkungen: |
Date Completed 31.10.2022 Date Revised 01.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/02676591211031462 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328002992 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328002992 | ||
003 | DE-627 | ||
005 | 20231225202031.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/02676591211031462 |2 doi | |
028 | 5 | 2 | |a pubmed24n1093.xml |
035 | |a (DE-627)NLM328002992 | ||
035 | |a (NLM)34254557 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fleet, Daniel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Experience with the Crescent® cannula for adult respiratory VV ECMO |b a case series |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.10.2022 | ||
500 | |a Date Revised 01.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: The Crescent® is a recently introduced dual lumen cannula by which veno-venous extracorporeal membrane oxygenation (VV ECMO) is delivered. It has a number of features that enhance its ease of placement, pressure-flow dynamics and may reduce catheter-related complication rates | ||
520 | |a METHODS: We present the first case series of its kind analysing this device by means of a retrospective observational study of prospectively collected data from the first year of its use in a high volume severe acute respiratory failure centre (Glenfield, UK). We compare complication rates of the Crescent®, with data from the international ELSO database and our own historic centre data and discuss subjective clinician experience of introducing this device | ||
520 | |a RESULTS: Over the first 12 months of its use (23/09/2019-23/09/2020), 54 patients were cannulated using a Crescent® catheter. There were no serious/life-threatening adverse events and a low number of minor cannula-related complications. Subjectively users found it has a number of advantages over other devices and configurations, not captured within current data collection frameworks | ||
520 | |a CONCLUSION: The Crescent® is a safe and effective device by which to deliver VV ECMO support to patients with severe acute respiratory failure | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a VV ECMO | |
650 | 4 | |a crescent | |
650 | 4 | |a dual-lumen cannula | |
650 | 4 | |a extracorporeal membrane oxygenation | |
650 | 4 | |a severe acute respiratory failure | |
700 | 1 | |a Morris, Idunn |e verfasserin |4 aut | |
700 | 1 | |a Faulkner, Gail |e verfasserin |4 aut | |
700 | 1 | |a Harvey, Chris |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Perfusion |d 1990 |g 37(2022), 8 vom: 17. Nov., Seite 819-824 |w (DE-627)NLM074653768 |x 1477-111X |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2022 |g number:8 |g day:17 |g month:11 |g pages:819-824 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/02676591211031462 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2022 |e 8 |b 17 |c 11 |h 819-824 |